| Aurora Las Encinas Hospital | |
| 2900 E Del Mar Blvd, Pasadena, California 91107 | |
| (866) 279-3709 | |
| Not Available |
| Name | Aurora Las Encinas Hospital |
|---|---|
| Type | Psychiatric Hospital |
| Location | 2900 E Del Mar Blvd, Pasadena, California |
| Ownership | Proprietary |
| Emergency Services | No |
| Medicare ID (CCN) | 054078 |
| NPI Number | 1700843216 |
| Organization Name | AURORA LAS ENCINAS, LLC |
| Doing Business As | AURORA LAS ENCINAS HOSPITAL |
| Address | 2900 E Del Mar Blvd, Pasadena, CA 91107 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 626-795-9901 |
News Archive
Prominent figures from the biometrics research and technologies sectors met at the University of Kent's Canterbury campus on Monday 2 April to celebrate the formation of the United Kingdom Biometrics Institute (UKBI).
Professor Adrian Mulholland and Dr Christopher Woods from Bristol's School of Chemistry, together with colleagues in Thailand, used graphics processing units (GPUs) to simulate the molecular processes that take place when these drugs are used to treat the H1N1-2009 strain of influenza - commonly known as 'swine flu'.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
VisiVite®, a world leader in eye vitamins, today announced its launch of a gentle new macular health formula: AREDS2 Silver®. Based on the National Eye Institute's Age-Related Eye Disease Studies (AREDS and AREDS2), AREDS2 Silver supplies antioxidants for macular health without the high levels of zinc that may cause issues in those with zinc sensitivities and allergies.
› Verified 5 days ago
News Archive
Prominent figures from the biometrics research and technologies sectors met at the University of Kent's Canterbury campus on Monday 2 April to celebrate the formation of the United Kingdom Biometrics Institute (UKBI).
Professor Adrian Mulholland and Dr Christopher Woods from Bristol's School of Chemistry, together with colleagues in Thailand, used graphics processing units (GPUs) to simulate the molecular processes that take place when these drugs are used to treat the H1N1-2009 strain of influenza - commonly known as 'swine flu'.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
VisiVite®, a world leader in eye vitamins, today announced its launch of a gentle new macular health formula: AREDS2 Silver®. Based on the National Eye Institute's Age-Related Eye Disease Studies (AREDS and AREDS2), AREDS2 Silver supplies antioxidants for macular health without the high levels of zinc that may cause issues in those with zinc sensitivities and allergies.
› Verified 5 days ago
Huntington Memorial Hospital Acute Care Hospital Location: 100 W California Blvd, Pasadena, California 91109 Phone: (626) 397-5000 | |
Aurora Las Encinas Hospital Psychiatric Hospital Location: 2900 E Del Mar Blvd, Pasadena, California 91107 Phone: (866) 279-3709 |